contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


modular-finance-ir-consensus-xvivo-perfusion-consensus-estimates-q2-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Xvivo Perfusion operates in the medical technology industry and focuses on the development and manufacturing of systems for organ transplantation and perfusion. Examples of products that the company supplies include cannulas, organ storage and cooling solutions. The company's products are aimed at healthcare institutions and surgeons. Xvivo Perfusion operates globally, was founded in 1998 and is headquartered in Gothenburg, Sweden.

Xvivo Perfusion

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.Number of contributors: 6 (all of which have been updated or confirmed before the report)KPI (MSEK, unless otherwise specified...

<div class="mfn-body"><p>Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.</p><p>Number of contributors: 6 (all of which have been updated or confirmed before the report)</p><table><tbody><tr><td rowspan="1" colspan="1"><strong>KPI (MSEK, unless otherwise specified)</strong></td><td rowspan="1" colspan="1" align="right"><strong>Q2 2024E</strong></td></tr><tr><td rowspan="1" colspan="1">Net sales</td><td rowspan="1" colspan="1" align="right">192</td></tr><tr><td rowspan="1" colspan="1">Organic growth in local currency (%)</td><td rowspan="1" colspan="1" align="right">22.2</td></tr><tr><td rowspan="1" colspan="1">Gross profit</td><td rowspan="1" colspan="1" align="right">141</td></tr><tr><td rowspan="1" colspan="1">EBITDA</td><td rowspan="1" colspan="1" align="right">36</td></tr><tr><td rowspan="1" colspan="1">EBIT</td><td rowspan="1" colspan="1" align="right">18</td></tr><tr><td rowspan="1" colspan="1">Net profit</td><td rowspan="1" colspan="1" align="right">16</td></tr><tr><td rowspan="1" colspan="1">Earnings per share (SEK)</td><td rowspan="1" colspan="1" align="right">0.52</td></tr><tr><td rowspan="1" colspan="1"><strong>Net sales per segment:</strong></td><td rowspan="1" colspan="1" align="right"><br></td></tr><tr><td rowspan="1" colspan="1">Thoracic</td><td rowspan="1" colspan="1" align="right">125</td></tr><tr><td rowspan="1" colspan="1">Abdominal</td><td rowspan="1" colspan="1" align="right">45</td></tr><tr><td rowspan="1" colspan="1">Services</td><td rowspan="1" colspan="1" align="right">22</td></tr></tbody></table><p>XVIVO Perfusion’s Q2 report will be released on Friday, 12 July, at 07:30 a.m. CEST.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/a79166b5-f251-48ce-b14e-24dfe6af2816/xvivo-perfusion-consensus-estimates-q2-2024.pdf" class="mfn-generated mfn-primary">XVIVO Perfusion – Consensus estimates Q2 2024</a></p></div>

Modular Finance IR Consensus: XVIVO Perfusion – Consensus estimates Q2 2024

Voittajan kirous

Yhdysvallat velkaantuu ja dollari heikkenee: Onko eurosta turvasatamaksi?

Pörsseissä ongitaan taas uusia huippuja, politikointi päällä Fed-valinnoissa

Pienyhtiöt ovat jääneet isoista jälkeen alkuvuoden nousumarkkinassa

Euroopan talouskasvu murrosvaiheessa: Mikä vielä pidättelee Eurooppaa?

KPI (MSEK, unless otherwise specified)	Q2 2024E
Net sales	192
Organic growth in local currency (%)	22.2
Gross profit	141
EBITDA	36
EBIT	18
Net profit	16
Earnings per share (SEK)	0.52
Net sales per segment:
Thoracic	125
Abdominal	45
Services	22